지역사회간호학회지 (Research in Community and Public Health Nursing)

  • 제29권3호
  • /
  • Pages.279-289
  • /
  • 2018
  • /
  • 1225-9594(pISSN)
  • /
  • 2288-4203(eISSN)
한국지역사회간호학회 (Korean Academy of Community Health Nursing)
권호 표지
DOI QR코드

DOI QR Code

HIV 감염인의 진단 후 치료 시작에 영향을 미치는 요인

Factors Influencing the Initiation of Treatment after the Diagnosis of Korean Patients with HIV

  • 심미소 (연세대학교 간호학과) ;
  • 김광숙 (연세대학교 간호대학.김모임 간호학연구소) ;
  • 박창기 (시카고 일리노이대학교 간호대학)
  • Shim, Mi-So (College of Nursing, Yonsei University) ;
  • Kim, Gwang Suk (College of Nursing.Mo-Im Kim Nursing Research Institute, Yonsei University) ;
  • Park, Chang Gi (College of Nursing, University of Illinois at Chicago)
  • 투고 : 2018.02.19
  • 심사 : 2018.07.21
  • 발행 : 2018.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: This study has been conducted to identify factors that influence the initiation of treatment after the diagnosis of Korean patients with HIV. Methods: A cross-sectional study design was used, and 290 patients with HIV from outpatient departments of 7 hospitals participated. Self-report questionnaires included items on the days from the primary diagnosis to the initiation of treatment, and the patients' demographic and disease related characteristics. Negative binomial regression model (NBR) was utilized to determine risk factors influencing the initiation of treatment after the diagnosis of the patients with HIV. Results: The skewness of days was 6.62, and the degree of asymmetry of distribution was severe. In NBR, patients who were in their 40s and 50s, female, unmarried and living with their family, jobless, in a middle or high level of economic status, and diagnosed before 2014 showed a higher risk of delayed treatment than patients who were younger, male, married and living with family, in a low level of economic status, and diagnosed in 2014 or afterwards. Conclusion: The findings suggest the necessity of intervention to promote HIV patients' early entry into treatment based on the participants' characteristics.

키워드

참고문헌

  1. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. The Lancet. 2013;382(9903):1525-1533. https://doi.org/10.1016/S0140-6736(13)61809-7
  2. The Joint United Nations Programme on HIV/AIDS. Ending AIDS: progress towards the 90-90-90 targets [Internet]. Geneva: The Joint United Nations Programme on HIV/AIDS. 2017 [cited 2018 January 3]. Available from: http://www.unaids.org/sites/default/files/media_asset/Global_AIDS_update_2017_en.pdf
  3. Korea Centers for Disease Control & Prevention. 2016 annual report on the notified patients with HIV/AIDS [Internet]. Cheongju: Korea Centers for Disease Control & Prevention. 2017 [cited 2017 March 24]. Available from: http://cdc.go.kr/CDC/mobile/info/CdcKrInfo0128.jsp?menuIds=HOME001-MNU1130-MNU1156-MNU1426-MNU1448&fid=3444&q_type=&q_value=&cid=75787&pageNum=
  4. Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial. The Lancet Infectious Diseases. 2014;14(4):281-290. https://doi.org/10.1016/S1473-3099(13)70692-3
  5. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. The New England Journal of Medicine. 2011;365(6):493-505. https://doi.org/10.1056/NEJMoa1105243
  6. Insight Start Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine. 2015;2015(373):795-807. https://doi.org/10.1056/NEJMoa1506816
  7. Centers for Disease Control & Prevention. Division of HIV/ AIDS Prevention Strategic Plan 2017-2020 [Internet]. Georgia: Centers for Disease Control & Prevention. 2018. [cited 2018 May 30]. Available from: https://www.cdc.gov/hiv/pdf/dhap/cdc-hiv-dhap-external-strategic-plan.pdf
  8. The Korean Society for AIDS. The 2013 clinical guidelines for the diagnosis and treatment of HIV/AIDS in HIV-infected Koreans. Infection & Chemotherapy. 2013;45(4):455-461. https://doi.org/10.3947/ic.2013.45.4.455
  9. Liu Y, Ruan Y, Vermund SH, Osborn CY, Wu P, Jia Y, et al. Predictors of antiretroviral therapy initiation: A cross-sectional study among Chinese HIV-infected men who have sex with men. BMC Infectious Diseases. 2015;15(1):570. https://doi.org/10.1186/s12879-015-1309-x
  10. Palmer AK, Cescon A, Chan K, Cooper C, Raboud JM, Miller CL, et al. Factors associated with late initiation of highly active antiretroviral therapy among young HIV-positive men and women aged 18 to 29 years in Canada. Journal of the International Association of Providers of AIDS Care. 2014;13 (1):56-62. https://doi.org/10.1177/2325957413510606
  11. Hsu LC, Truong HHM, Vittinghoff E, Zhi Q, Scheer S, Schwarcz S. Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007-2011. The Journal of Infectious Diseases. 2013; 209(9):1310-1314. https://doi.org/10.1093/infdis/jit599
  12. Alvarez-Uria G. Factors associated with delayed entry into HIV medical care after HIV diagnosis in a resource-limited setting: data from a cohort study in India. PeerJ. 2013;1:e90. https://doi.org/10.7717/peerj.90
  13. Plitt SS, Mihalicz D, Singh AE, Jayaraman G, Houston S, Lee BE. Time to testing and accessing care among a population of newly diagnosed patients with HIV with a high proportion of Canadian Aboriginals, 1998-2003. AIDS Patient Care and STDs. 2009;23(2):93-99. https://doi.org/10.1089/apc.2007.0238
  14. Newman CE, Bonar M, Greville HS, Thompson SC, Bessarab D, Kippax SC. Barriers and incentives to HIV treatment uptake among Aboriginal people in Western Australia. AIDS. 2007; 21:S13-S17. https://doi.org/10.1097/01.aids.0000255080.46976.18
  15. Begley K, McLaws ML, Ross MW, Gold J. Cognitive and behavioural correlates of non-adherence to HIV anti-retroviral therapy: Theoretical and practical insight for clinical psychology and health psychology. Clinical Psychologist. 2008;12(1):9-17. https://doi.org/10.1080/09540121.2015.1114992
  16. Park Y, Seo MJ, Kim S, Park S. Experience of treatment adherence in Korean patients with HIV. Journal of Korean Academy of Nursing. 2014;44(4):407-417. https://doi.org/10.4040/jkan.2014.44.4.407
  17. Park YM, Shin G, Kim J. Factors influencing health-promoting behaviors in people living with HIV. Korean Journal of Adult Nursing. 2014;26(2):234-243. https://doi.org/10.7475/kjan.2014.26.2.234
  18. Coxe S, West SG, Aiken LS. The analysis of count data: a gentle introduction to Poisson regression and its alternatives. Journal of Personality Assessment. 2009;91(2):121-136. https://doi.org/10.1080/00223890802634175
  19. Alvarez-Uria G, Pakam R, Midde M, Naik PK. Predictors of delayed antiretroviral therapy initiation, mortality, and loss to followup in HIV infected patients eligible for HIV treatment: Data from an HIV cohort study in India. BioMed Research International. 2013;2013:849042. https://doi.org/10.1155/2013/849042
  20. Cescon A, Patterson S, Davey C, Ding E, Raboud JM, Chan K, et al. Late initiation of combination antiretroviral therapy in Canada: A call for a national public health strategy to improve engagement in HIV care. Journal of the International AIDS Society. 2015;18(1):20024. https://doi.org/10.7448/IAS.18.1.20024
  21. Kohli R, Klein RS, Schoenbaum EE, Anastos K, Minkoff H, Sacks HS. Aging and HIV infection. Journal of Urban Health. 2006;83(1):31-42. https://doi.org/10.1007/s11524-005-9005-6
  22. Illa L, Echenique M, Jean GS, Bustamante-Avellaneda V, Metsch L, Mendez-Mulet L, et al. Project ROADMAP: Reeducating Older Adults in Maintaining AIDS Prevention: A secondary intervention for older HIV-positive adults. AIDS Education & Prevention. 2010;22(2):138-147. https://doi.org/10.1521/aeap.2010.22.2.138
  23. Messer LC, Quinlivan EB, Parnell H, Roytburd K, Adimora AA, Bowditch N, et al. Barriers and facilitators to testing, treatment entry, and engagement in care by HIV-positive women of color. AIDS Patient Care and STDs. 2013;27(7):398-407. https://doi.org/10.1089/apc.2012.0435
  24. Logie CH, James L, Tharao W, Loutfy MR. HIV, gender, race, sexual orientation, and sex work: A qualitative study of intersectional stigma experienced by HIV-positive women in Ontario, Canada. PLoS Medicine. 2011;8(11):e1001124. https://doi.org/10.1371/journal.pmed.1001124
  25. Alfonso V, Bermbach N, Geller J, Montaner JS. Individual variability in barriers affecting people's decision to take HAART: A qualitative study identifying barriers to being on HAART. AIDS Patient Care & STDs. 2006;20(12):848-857. https://doi.org/10.1089/apc.2006.20.848
  26. Seo MH, Jeong SH. Life experiences of uninfected women living with HIV-infected husbands: A phenomenological study. Journal of Korean Academy of Nursing. 2017;47(6):781-793. https://doi.org/10.4040/jkan.2017.47.6.781
  27. Nakimuli-Mpungu E, Wamala K, Okello J, Alderman S, Odokonyero R, Mojtabai R, et al. Group support psychotherapy for depression treatment in people with HIV/AIDS in northern Uganda: A single-centre randomised controlled trial. The Lancet HIV. 2015;2(5):e190-e199. https://doi.org/10.1016/S2352-3018(15)00041-7
  28. Fox MP, Mazimba A, Seidenberg P, Crooks D, Sikateyo B, Rosen S. Barriers to initiation of antiretroviral treatment in rural and urban areas of Zambia: A cross-sectional study of cost, stigma, and perceptions about ART. Journal of the International AIDS Society. 2010;13(1):8. https://doi.org/10.1186/1758-2652-13-8
  29. Posse M, Baltussen R. Barriers to access to antiretroviral treatment in Mozambique, as perceived by patients and health workers in urban and rural settings. AIDS Patient Care and STDs. 2009;23(10):867-875. https://doi.org/10.1089/apc.2009.0050.
  30. Korea Centers for Disease Control & Prevention. 2018 HIV/ AIDS management guideline [Internet]. Cheongju: Korea Centers for Disease Control & Prevention. 2017 [cited 2018 May 30]. Available from: http://www.cdc.go.kr/CDC/cms/content/mobile/74/77274_view.html